Plasma Transthyretin as a Predictor of Amnestic Mild Cognitive Impairment Conversion to Dementia

Amnestic mild cognitive impairment (MCI) is a prodromal stage of dementia, with a higher incidence of these patients progressing to Alzheimer’s disease (AD) than normal aging people. A biomarker for the early detection and prediction for this progression is important. We recruited MCI subjects in th...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sci Rep
Hlavní autoři: Tien, Yi-Ting, Lee, Wei-Ju, Liao, Yi-Chu, Wang, Wen-Fu, Jhang, Kai-Ming, Wang, Shuu-Jiun, Fuh, Jong-Ling
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6904474/
https://ncbi.nlm.nih.gov/pubmed/31822765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-55318-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky